Back
EPAM Systems Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
4
EPAM
EPAM Systems
Last Price:
$164.96
Seasonality Move:
13.08%
Sell
33
APLS
Apellis Pharmaceuticals
Last Price:
$17.77
Seasonality Move:
-0.62%
Sell
4
EPAM Systems (EPAM)
is a Sell
Is EPAM Systems a Buy, Sell or Hold?
-
The current EPAM Systems [EPAM] share price is $165.02. The Score for EPAM is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
-
EPAM is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $17.76. The Score for APLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EPAM Stock Price Chart
What is EPAM Systems's stock price today?
-
The EPAM Systems share price today is $165.02The current trend is moderately bearish and EPAM is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $17.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.
EPAM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.88 | Buy |
Relative Strength Index (14 RSI): | 38.79 | Sell |
Chaikin Money Flow: | -438903 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (171.54 - 182.2) | Sell |
Bollinger Bands (100): | (153.55 - 226.65) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 43.51 | Sell |
Chaikin Money Flow: | 37954 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.12 - 19.06) | Sell |
Bollinger Bands (100): | (17.79 - 26.73) | Sell |
EPAM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 173.35 | Sell |
20-day SMA: | 174.97 | Sell |
50-day SMA: | 167.6 | Sell |
200-day SMA: | 204.27 | Sell |
8-day EMA: | 171.52 | Sell |
20-day EMA: | 173.16 | Sell |
50-day EMA: | 157.67 | Buy |
200-day EMA: | 78.8 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.77 | Sell |
20-day SMA: | 18.28 | Sell |
50-day SMA: | 18.29 | Sell |
200-day SMA: | 26.93 | Sell |
8-day EMA: | 18.41 | Sell |
20-day EMA: | 18.43 | Sell |
50-day EMA: | 19.3 | Sell |
200-day EMA: | 27.06 | Sell |
EPAM Systems Earnings Growth & EPAM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.64 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.04 per share, and an increase next year of $1.22 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.
EPAM Systems Technical Analysis
Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |